摘要
对 374例孕中期作羊膜腔穿刺的母亲及所分娩的 2 87例婴儿进行随访。观察到流产率为 0 2 7%。早产率5 2 3%、先天性畸形 3 48%。经分析其原因均与羊膜腔穿刺无关 ,提示孕中期在B超监护下作羊膜腔穿刺术是一种安全的产前诊断方法。
出处
《中国优生与遗传杂志》
2000年第5期78-79,共2页
Chinese Journal of Birth Health & Heredity
参考文献5
-
1Schwards RH. Amniocentesis. Chin Obstet Gynecol, 1975,18(2):14-19.
-
2Hunter AGW, Thompson D, Speevak M. Ridtrimester genetic amniocentesis in Eastern Ontario:a review from 1970 to 1985.J Med Genetics, 1987, 24: 335-343.
-
3Bombard AT, Powers JF, Carter S, et al. Procedure-related fetal losses in transplacental versus nontransplacental genetic amniocentesis. Am J Obstet Gynecol, 1995, 172:868-872.
-
4Philip J, Bang J. Outcome of pregnancy after amniocentesis for chromosome analysis. Br Med J, 1978, 2:1183-1184.
-
5Opitz JM, Laxova R, Herrmann J. Intrauterine amputations after amniocentesis. Lancet, 1978,1:716.
同被引文献14
-
1In't Anker PS,Noort WA,Scherjon SA,et al.Mesenchymal stem cells in human second-trimester bone marrow,liver,lung,and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential.Haematologica,2003,88:845-852.
-
2Hu Y,Liao L,Wang Q,et al.Isolation and identification of mesenchymal stem cells from human fetal pancreas.J Lab Clin Med,2003,141:342-349.
-
3In't Anker PS,Scherjon SA,Kleijburg-van der Keur C,et al.Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta.Stem Cells,2004,22:1338-1345.
-
4Campagnoli C,Roberts IA,Kumar S,et al.Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood,liver,and bone marrow.Blood,2001,98:2396-2402.
-
5Chan J,O'Donoghue K,de la Fuente J,et al.Human fetal mesenchymal stem cells as vehicles for gene delivery.Stem Cells,2005,23:93-102.
-
6Prusa AR,Marton E,Rosner M,et al.Oct-4-expressing cells in human amniotic fluid:A new source for stem cell research? Hum Reprod,2003,18:1489-1493.
-
7Pittenger MF,Mackay AM,Beck SC,et al.Multilineage potential of adult human mesenchymal stem cells.Science,1999,284:143-147.
-
8Petersen BE,Bowen WC,Patrene KD,et al.Bone marrow as a potential source of hepatic oval cells.Science,1999,284:1168-1170.
-
9Tremain N,Korkko J,Ibberson D,et al.MicroSAGE analysis of 2353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages.Stem Cells,2001,19:408-418.
-
10Van Damme A,Vanden Driessche T,Collen D,et al.Bone marrow stromal cells as targets for gene therapy.Curr Gene Ther,2002,2:195-209.
二级引证文献7
-
1郭素红,苑春华,刘慧玲,李欣.不同来源人的间充质干细胞分离与基本生物学特性的研究[J].吉林医药学院学报,2010,31(5):249-251.
-
2朱哲,潘骏,李现铎,耿红全,陈方.孕中期羊水来源胎儿间充质干细胞体外诱导为平滑肌细胞的研究[J].中华小儿外科杂志,2006,27(12):617-621. 被引量:4
-
3张瑞锋,吴金英,姚金凤,张阳,李中秋,周东平.间充质干细胞的来源[J].中国组织工程研究与临床康复,2007,11(15):2968-2970. 被引量:5
-
4朱哲,潘骏,张亮,耿红全,谢华,陈方.免疫磁珠分离羊水来源OCT-4阳性胎儿干细胞的实验研究[J].中华小儿外科杂志,2007,28(11):598-601. 被引量:4
-
5冯建勋,腊晓林,马艳,毕晓娟,温浩.两步法分离和培养人羊水来源胚胎间充质干细胞的生物学特征[J].中国组织工程研究与临床康复,2009,13(45):8854-8860. 被引量:8
-
6郭素红,苑春华,侯毅鞠,刘会玲.人羊水间充质干细胞分离培养方法的优化[J].中国组织工程研究与临床康复,2011,15(10):1837-1840. 被引量:1
-
7郭素红,苑春华,刘会玲,李欣,许会静.不同孕期羊水间充质干细胞体外培养方法的比较[J].中国组织工程研究与临床康复,2011,15(14):2605-2608. 被引量:1
-
1马渑霞.剖宫产术后留置尿管不同时间的安全性探讨[J].实用护理杂志(下半月),2003,19(08B):51-51. 被引量:14
-
2王龙.腹腔镜胆囊切除术并发症的防治[J].基层医学论坛,2008,12(11):324-324.
-
3董琴.曼月乐环治疗子宫腺肌病患者的疗效观察和安全性探讨[J].中外女性健康研究,2016(9):50-50. 被引量:2
-
4吴素彬,苏雪芳,谢开.早孕绒毛制备染色体及取材安全性探讨[J].新医学,1989,20(1):20-21.
-
5卫金线,褚艳蓉.剖宫产后再次妊娠者经阴道分娩的安全性探讨[J].中国实用医药,2012,7(11):112-112. 被引量:3
-
6雷敏宜,关涛,梁丽玉.瘢痕子宫再次妊娠者经阴道分娩安全性探讨[J].牡丹江医学院学报,2017,38(1):64-65. 被引量:1
-
7宋秀莲.剖宫产术后再次足月妊娠阴道分娩的安全性探讨[J].中国现代医药杂志,2012,14(1):84-85. 被引量:20
-
8张静茹.米非司酮联合血府逐瘀胶囊治疗异位妊娠的疗效观察及安全性探讨[J].医学综述,2012,18(15):2505-2506. 被引量:6
-
9李肖.剖宫产术中行子宫肌瘤剔除安全性探讨[J].中外妇儿健康(学术版),2011,19(7):83-83.
-
10唐俐.剖宫产术后再次妊娠阴道分娩安全性探讨[J].中外医学研究,2016,14(29):154-155. 被引量:7